» Articles » PMID: 6154900

L-kynurenine: Its Synthesis and Possible Regulatory Function in Brain

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 1980 Mar 1
PMID 6154900
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

One pathway by which tryptophan is metabolized in the brain as well as in the periphery is through cleavage of the indole ring to formylkynurenine and then kynurenine. Indoleamine-2,3-dioxygenase, the enzyme that catalyzes this cleavage, and kynurenine are distributed all across the different anatomic regions of brain. Approximately 40% of the kynurenine in brain is synthesized there, the remainder having come from plasma. Tryptophan loading, which has been used both experimentally and therapeutically as a means of increasing tryptophan conversion to serotonin, also increases kynurenine formation in the brain and in the periphery. Because of the formation of kynurenine, which competes for cerebral transport and cellular uptake of L-tryptophan, and because of substrate inhibition on tryptophan hydroxylase, excessively high doses of tryptophan may actually decrease the production of cerebral serotonin and 5-hydroxyindoleacetic acid.

Citing Articles

Importance of Modulating Kynurenic Acid Metabolism-Approaches for the Treatment of Dementia.

Baran H, Jan Pietryja M, Kepplinger B Biomolecules. 2025; 15(1).

PMID: 39858468 PMC: 11764436. DOI: 10.3390/biom15010074.


The major biogenic amine metabolites in mood disorders.

Yang J, Yuan M, Zhang W Front Psychiatry. 2024; 15:1460631.

PMID: 39381610 PMC: 11458445. DOI: 10.3389/fpsyt.2024.1460631.


Tryptophan Metabolism in Obesity: The Indoleamine 2,3-Dioxygenase-1 Activity and Therapeutic Options.

Engin A, Engin A Adv Exp Med Biol. 2024; 1460:629-655.

PMID: 39287867 DOI: 10.1007/978-3-031-63657-8_21.


Role of Kynurenine and Its Derivatives in the Neuroimmune System.

Fujikawa M, Ueda M, Maruyama K Int J Mol Sci. 2024; 25(13).

PMID: 39000249 PMC: 11241229. DOI: 10.3390/ijms25137144.


The roles of the kynurenine pathway in COVID-19 neuropathogenesis.

Dehhaghi M, Heydari M, Kazemi Shariat Panahi H, Lewin S, Heng B, Brew B Infection. 2024; 52(5):2043-2059.

PMID: 38802702 PMC: 11499433. DOI: 10.1007/s15010-024-02293-y.


References
1.
Curzon G, Green A . Regional and subcellular changes in the concentration of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat brain caused by hydrocortisone, DL- -methyl-tryptophan l-kynurenine and immobilization. Br J Pharmacol. 1971; 43(1):39-52. PMC: 1665949. DOI: 10.1111/j.1476-5381.1971.tb07155.x. View

2.
Gal E . Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain. J Neurochem. 1974; 22(5):861-3. DOI: 10.1111/j.1471-4159.1974.tb04306.x. View

3.
SHIELDS P, Eccleston D . Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain. J Neurochem. 1973; 20(3):881-8. DOI: 10.1111/j.1471-4159.1973.tb00048.x. View

4.
Bailey C, Wagner C . Kynurenine formamidase. Purification and characterization of the adult chicken liver enzyme and immunochemical analyses of the enzyme of developing chicks. J Biol Chem. 1974; 249(14):4439-44. View

5.
Frieden E, WESTMARK G, SCHOR J . Inhibition of tryptophan pyrrolase by serotonin, epinephrine and tryptophan analogs. Arch Biochem Biophys. 1961; 92:176-82. DOI: 10.1016/0003-9861(61)90233-8. View